|
Drug Resistance:
Lee JJ, Hughes CS, Fine RL, Page RL. Pgp expression in canine lymphoma: A
Relevant, intermediate model of multidrug resistance. Cancer 77:1892-1898, 1996.
Steingold SS, Sharp NJ, McGahan C, Hughes CS, Denn SE, Page RL.
Characterization of canine MDR1 messenger RNA and its abundance in drug
resistant cell lines and in vivo. AntiCancer Res 18:393-400, 1998.
Waddle JR, Fine RL, Case BC, Trogdon ML, Tyczkowska K, Frazier D, Page
RL. Phase I and pharmacokinetic analysis of high-dose tamoxifen plus
chemotherapy in normal and tumor-bearing dogs. Cancer Chemotherapy and
Pharmacology 44:74-80, 1999.
Lymphocyte Immunobiology:
Ruslander DA, Grindem CB, Gebhard D, Price GS, Page RL. Immunophenotypic
characterization of canine lymphoproliferative disorders. In Vivo 11:169-172, 1997.
Grindem CB, Page RL, Ammerman BE, Breitschwerdt EB. Immunophenotypic
comparison of blood and lymph node from dogs with lymphoma. Vet Clinical
Pathology 27:16-20, 1998.
Radiation Therapy:
Cronin KL, Page RL, Spodnick G, Price GS, Ruslander DA, Thrall DE. Radiation
Therapy and surgery in the treatment of fibrosarcomas in cats. Vet Radiology and
Ultrasound 39:51-56, 1998.
LaDue-Miller TL, Price GS, Dodge R, Page RL, Thrall DE. Radiation therapy for
incompletely resected canine mast cell tumors. Vet Radiology and Ultrasound
39:57-62, 1998.
LaDue TA, Dodge R, Page RL, Price SL, Hauck ML, Thrall DE. Prognostic
factors influencing survival after radiotherapy of nasal tumors in 130 dogs. Vet
Radiology and Ultrasound 40:312-317,1999.
Ramirez O, Dodge RK, Page RL, Price GS, Hauck ML, LaDue TA, Thrall DE.
Palliative radiotherapy in the treatment of canine appendicular osteosarcoma in 95
dogs. Vet Radiology and Ultrasound - In press.
|
